CRISPR Insider™

CRISPR News and Information from Around The World

New CRISPR method efficiently corrects Duchenne muscular dystrophy defect in heart tissue

Posted by btwatson on February 7, 2018 8:26 am
Tags:
Categories: Uncategorized

Source: New CRISPR method efficiently corrects Duchenne muscular dystrophy defect in heart tissue

[unable to retrieve full-text content]

  1. New CRISPR method efficiently corrects Duchenne muscular dystrophy defect in heart tissue  Science Daily
  2. New CRISPR method efficiently corrects DMD defect in heart tissue  Phys.Org
  3. Two Types of CRISPR Gene Editing Could Be Useful in Treating Sickle Cell Anemia, Editas Reports  Sickle Cell Anemia News
  4. Full coverage

Published at Tue, 06 Feb 2018 19:57:56 +0000

Leave a Reply Cancel reply

You must be logged in to post a comment.

< CRISPR Insider™ home

Crispr News

  • Worldwide CRISPR Market In-Depth Analysed Research Report 2021 – Clark County Blog - Clark County Blog
    April 18, 2021
  • [PDF] Global Clustered Regularly Interspaced Short Palindromic Repeats(CRISPR) Technology Market Segments, Share, Trends 2027 | Thermo Fisher Scientific, Merck, GenScript, Integrated DNA Technologies, Horizon Discovery Group, Agilent Technologies - SoccerNurds
    April 18, 2021
  • Incredible Growth of CRISPR Technology Market 2021 Growing with Major Eminent Key Players Thermo Fisher Scientific, Merck KGaA, GenScript, Integrated DNA Technologies (IDT) - Los Hijos de la Malinche
    April 17, 2021
  • ‘The Code Breaker’ review: The quest to rewrite DNA - The Hindu
    April 17, 2021
  • CRISPR Gene Editing Tools Market to See Strong Expansion Through 2027 Covid-19 Analysis – KSU | The Sentinel Newspaper - KSU | The Sentinel Newspaper
    April 17, 2021
  • CRISPR Stocks: The Big Analyst Call Destroying CRSP, NTLA, EDIT Stocks Today - Nasdaq
    April 16, 2021
  • CRISPR Gene Editing in Sub-Saharan Africa - BORGEN - Borgen Project
    April 16, 2021
  • Global CRISPR Genome Editing Market SWOT Analysis, Key Indicators, Forecast 2027 : Editas Medicine, CRISPR Therapeutics AG – The Courier - The Courier
    April 16, 2021
  • CRISPR Technology Market Restraints, Overview Highlighting Major Drivers, Trends, Growth and Demand Report 2020- 2027 – KSU | The Sentinel Newspaper - KSU | The Sentinel Newspaper
    April 16, 2021
  • Crispr And Cas Genes Market to Grow with Sustainable CAGR During 2020 – 2027 | Key Players – CRISPR Therapeutics, Genscrip, AstraZeneca. – KSU | The Sentinel Newspaper - KSU | The Sentinel Newspaper
    April 16, 2021
  • World CRISPR Gene Detection and Diagnostic Markets 2021-2025: Market has Just Gotten Started with a Handful of Small Startups - Expect the Big Players to Start Taking Notice - GlobeNewswire
    April 16, 2021
  • Reversible CRISPR, Life-Extending Young Blood, and the Rise of Robo-Advisors – ShareCafe - ShareCafe
    April 16, 2021
  • Parallel Genome Editing in Microscopic Worms Maps Regulatory Genomic Elements to Physiology - Genetic Engineering & Biotechnology News
    April 16, 2021
  • An 'off button' for pain? CRISPR could stop the opioid crisis by tackling chronic pain at the source - Genetic Literacy Project
    April 16, 2021
  • A New Clinical Trial Will Explore Gene Editing For Sickle Cell Disease - Verywell Health
    April 16, 2021
  • CRISPR rivals put patents aside to help in fight against Covid-19 – STAT
    CRISPR rivals put patents aside to help in fight against Covid-19 – STAT
  • CRISPR 2.0: Base Editing in the Groove – Genetic Engineering & Biotechnology News
  • The Promises of CRISPR Genome Editing in Biomedicine – Labiotech.eu
    The Promises of CRISPR Genome Editing in Biomedicine – Labiotech.eu
  • The Code Breaker and Crispr People — the ethics of editing humanity – Financial Times
  • ERS Genomics Licenses CRISPR Patents to CRO ZeClinics – GenomeWeb
    ERS Genomics Licenses CRISPR Patents to CRO ZeClinics – GenomeWeb
  • The Dark Side of CRISPR – Scientific American
    The Dark Side of CRISPR – Scientific American
  • ERS Genomics and ZeClinics Sign CRISPR/Cas9 License Agreement – BioSpace
    ERS Genomics and ZeClinics Sign CRISPR/Cas9 License Agreement – BioSpace
  • Scientists Use CRISPR To Create Model of AML Progression – AJMC.com Managed Markets Network
    Scientists Use CRISPR To Create Model of AML Progression – AJMC.com Managed Markets Network
  • DECODR app identifies DNA mutations from CRISPR gene therapies – European Pharmaceutical Review
    DECODR app identifies DNA mutations from CRISPR gene therapies – European Pharmaceutical Review
  • CRISPR/Cas technology as a promising weapon to combat viral infections – Wiley
    CRISPR/Cas technology as a promising weapon to combat viral infections – Wiley
  • Neanderthal-like ‘mini-brains’ created in lab with CRISPR – Nature.com
    Neanderthal-like ‘mini-brains’ created in lab with CRISPR – Nature.com
  • Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – Phys.org
    Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – Phys.org
  • Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – EurekAlert
    Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – EurekAlert
  • New CRISPR tech targets human genome’s complex code: Programmable CRISPR/Cas9-based kinase offers insights into, control over regulatory histone proteins – Science Daily
    New CRISPR tech targets human genome’s complex code: Programmable CRISPR/Cas9-based kinase offers insights into, control over regulatory histone proteins – Science Daily
  • After ditching Editas, AbbVie taps Caribou for new CRISPR, CAR-T pact – FierceBiotech
    After ditching Editas, AbbVie taps Caribou for new CRISPR, CAR-T pact – FierceBiotech
  • Load more [+]

Copyright 2020 CrisprInsider.com